Autologous bone marrow mononuclear cell therapy improves symptoms in patients with end-stage peripheral arterial disease and reduces inflammation-associated parameters

Cytotherapy

Volumn 16, Issue 9, 2014, Pages 1270-1279

  Malyar, Nasser M ^a   Radtke, Stefan ^b   Malyar, Khalil ^b   Arjumand, Jawed ^c   Horn, Peter A ^b   Kröger, Knut ^d   Freisinger, Eva ^a   Reinecke, Holger ^a   Giebel, Bernd ^b   Brock, Franz Eduard ^b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c Agaplesion Bethesda Krankenhaus Wuppertal   (Germany)

^d HELIOS Klinik Krefeld   (Germany)

Author keywords

Autologous mononuclear cells; Cell based therapy; Critical limb ischemia; End stage peripheral arterial disease; Inflammation

Indexed keywords

C REACTIVE PROTEIN; FLUCLOXACILLIN; INTERLEUKIN 6; AUTACOID;

ADULT; ANKLE BRACHIAL INDEX; ARTERIOGRAPHY; ARTERY PERFUSION; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CELL DENSITY; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; DENSITY GRADIENT CENTRIFUGATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; MALE; MIDDLE AGED; OXYGEN TENSION; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SINGLE DRUG DOSE; TISSUE OXYGENATION; TISSUE PERFUSION; AGED; AUTOTRANSPLANTATION; BLOOD; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; DISEASE COURSE; FOLLOW UP; IMMUNOLOGY; LIMB SALVAGE; METABOLISM; MONONUCLEAR CELL; PERIPHERAL ARTERIAL DISEASE; PHYSIOLOGY; PROCEDURES; TRANSPLANTATION; TREATMENT OUTCOME; WOUND HEALING;

AGED; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; C-REACTIVE PROTEIN; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; LEUKOCYTES, MONONUCLEAR; LIMB SALVAGE; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; WOUND HEALING;

EID: 84905562160     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1016/j.jcyt.2014.05.001     Document Type: Article

References (45)

1. Norgren L., Hiatt W.R., Dormandy J.A., Nehler M.R., Harris K.A., Fowkes F.G., et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg 2007, 33(Suppl 1):S1-75.
2. Becker F., Robert-Ebadi H., Ricco J.B., Setacci C., Cao P., de Donato G., et al. Chapter I: Definitions, Epidemiology, Clinical Presentation and Prognosis. Eur J Vasc Endovasc Surg 2011, 42(Suppl 2):S4-12.
3. Malyar N., Furstenberg T., Wellmann J., Meyborg M., Luders F., Gebauer K., et al. Recent trends in morbidity and in-hospital outcomes of in-patients with peripheral arterial disease: a nationwide population-based analysis. Eur Heart J 2013, 34:2706-2714.
4. Benoit E., O'Donnell T.F., Iafrati M.D., Asher E., Bandyk D.F., Hallett J.W., et al. The role of amputation as an outcome measure in cellular therapy for critical limb ischemia: implications for clinical trial design. J Transl Med 2011, 9:165.
5. Benoit E., O'Donnell T.F., Kitsios G.D., Iafrati M.D. Improved amputation-free survival in unreconstructable critical limb ischemia and its implications for clinical trial design and quality measurement. J Vasc Surg 2012, 55:781-789.
6. Benoit E., O'Donnell T.F., Patel A.N. Safety and efficacy of autologous cell therapy in critical limb ischemia: a systematic review. Cell Transplant 2013, 22:545-562.
7. Hirsch A.T., Haskal Z.J., Hertzer N.R., Bakal C.W., Creager M.A., Halperin J.L., et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 2006, 113:e463-e654.
8. Amann B., Luedemann C., Ratei R., Schmidt-Lucke J.A. Autologous bone marrow cell transplantation increases leg perfusion and reduces amputations in patients with advanced critical limb ischemia due to peripheral artery disease. Cell Transplant 2009, 18:371-380.
9. Idei N., Soga J., Hata T., Fujii Y., Fujimura N., Mikami S., et al. Autologous bone-marrow mononuclear cell implantation reduces long-term major amputation risk in patients with critical limb ischemia: a comparison of atherosclerotic peripheral arterial disease and Buerger disease. Circ Cardiovasc Interv 2011, 4:15-25.
10. Powell R.J., Comerota A.J., Berceli S.A., Guzman R., Henry T.D., Tzeng E., et al. Interim analysis results from the RESTORE-CLI, a randomized, double-blind multicenter phase II trial comparing expanded autologous bone marrow-derived tissue repair cells and placebo in patients with critical limb ischemia. J Vasc Surg 2011, 54:1032-1041.
11. Tateishi-Yuyama E., Matsubara H., Murohara T., Ikeda U., Shintani S., Masaki H., et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 2002, 360:427-435.
12. Walter D.H., Krankenberg H., Balzer J.O., Kalka C., Baumgartner I., Schluter M., et al. Intraarterial administration of bone marrow mononuclear cells in patients with critical limb ischemia: a randomized-start, placebo-controlled pilot trial (PROVASA). Circ Cardiovasc Interv 2011, 4:26-37.
13. Posel C., Moller K., Frohlich W., Schulz I., Boltze J., Wagner D.C. Density gradient centrifugation compromises bone marrow mononuclear cell yield. PLoS One 2012, 7:e50293.
14. Ziegelhoeffer T., Fernandez B., Kostin S., Heil M., Voswinckel R., Helisch A., et al. Bone marrow-derived cells do not incorporate into the adult growing vasculature. Circ Res 2004, 94:230-238.
15. Folkman J., D'Amore P.A. Blood vessel formation: what is its molecular basis?. Cell 1996, 87:1153-1155.
16. Ito W.D., Arras M., Winkler B., Scholz D., Schaper J., Schaper W. Monocyte chemotactic protein-1 increases collateral and peripheral conductance after femoral artery occlusion. Circ Res 1997, 80:829-837.
17. Kinnaird T., Stabile E., Burnett M.S., Lee C.W., Barr S., Fuchs S., et al. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 2004, 94:678-685.
18. McCourt M., Wang J.H., Sookhai S., Redmond H.P. Proinflammatory mediators stimulate neutrophil-directed angiogenesis. Arch Surg 1999, 134:1325-1331.
19. Rehman J., Li J., Orschell C.M., March K.L. Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 2003, 107:1164-1169.
20. Lawall H., Bramlage P., Amann B. Stem cell and progenitor cell therapy in peripheral artery disease: a critical appraisal. Thromb Haemost 2010, 103:696-709.
21. Gnecchi M., Danieli P., Cervio E. Mesenchymal stem cell therapy for heart disease. Vascul Pharmacol 2012, 57:48-55.
22. Przybyt E., Harmsen M.C. Mesenchymal stem cells: promising for myocardial regeneration?. Curr Stem Cell Res Ther 2013, 8:270-277.
23. Wen Z., Zheng S., Zhou C., Wang J., Wang T. Repair mechanisms of bone marrow mesenchymal stem cells in myocardial infarction. J Cell Mol Med 2011, 15:1032-1043.
24. Lee R.H., Pulin A.A., Seo M.J., Kota D.J., Ylostalo J., Larson B.L., et al. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 2009, 5:54-63.
25. Kordelas L., Rebmann V., Ludwig A.K., Radtke S., Ruesing J., Doeppner T.R., et al. MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease. Leukemia 2014, 28:970-973.
26. Lai R.C., Arslan F., Lee M.M., Sze N.S., Choo A., Chen T.S., et al. Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res 2010, 4:214-222.
27. Ludwig A.K., Giebel B. Exosomes: small vesicles participating in intercellular communication. Int J Biochem Cell Biol 2012, 44:11-15.
28. Rutherford R.B., Baker J.D., Ernst C., Johnston K.W., Porter J.M., Ahn S., et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg 1997, 26:517-538.
29. Tendera M., Aboyans V., Bartelink M.L., Baumgartner I., Clement D., Collet J.P., et al. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J 2011, 32:2851-2906.
30. Marston W.A., Davies S.W., Armstrong B., Farber M.A., Mendes R.C., Fulton J.J., et al. Natural history of limbs with arterial insufficiency and chronic ulceration treated without revascularization. J Vasc Surg 2006, 44:108-114.
31. Pinzur M.S., Sage R., Stuck R., Ketner L., Osterman H. Transcutaneous oxygen as a predictor of wound healing in amputations of the foot and ankle. Foot Ankle 1992, 13:271-272.
32. Giebel B., Corbeil D., Beckmann J., Hohn J., Freund D., Giesen K., et al. Segregation of lipid raft markers including CD133 in polarized human hematopoietic stem and progenitor cells. Blood 2004, 104:2332-2338.
33. Teraa M., Sprengers R.W., van der Graaf Y., Peters C.E., Moll F.L., Verhaar M.C. Autologous bone marrow-derived cell therapy in patients with critical limb ischemia: a meta-analysis of randomized controlled clinical trials. Ann Surg 2013, 258:922-929.
34. Higashi Y., Kimura M., Hara K., Noma K., Jitsuiki D., Nakagawa K., et al. Autologous bone-marrow mononuclear cell implantation improves endothelium-dependent vasodilation in patients with limb ischemia. Circulation 2004, 109:1215-1218.
35. Kamihata H., Matsubara H., Nishiue T., Fujiyama S., Amano K., Iba O., et al. Improvement of collateral perfusion and regional function by implantation of peripheral blood mononuclear cells into ischemic hibernating myocardium. Arterioscler Thromb Vasc Biol 2002, 22:1804-1810.
36. Schillinger M., Exner M., Mlekusch W., Rumpold H., Ahmadi R., Sabeti S., et al. Vascular inflammation and percutaneous transluminal angioplasty of the femoropopliteal artery: association with restenosis. Radiology 2002, 225:21-26.
37. Szmitko P.E., Wang C.H., Weisel R.D., de Almeida J.R., Anderson T.J., Verma S. New markers of inflammation and endothelial cell activation, part I. Circulation 2003, 108:1917-1923.
38. Szmitko P.E., Wang C.H., Weisel R.D., Jeffries G.A., Anderson T.J., Verma S. Biomarkers of vascular disease linking inflammation to endothelial activation, part II. Circulation 2003, 108:2041-2048.
39. Verma S., Kuliszewski M.A., Li S.H., Szmitko P.E., Zucco L., Wang C.H., et al. C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease. Circulation 2004, 109:2058-2067.
40. Verma S., Li S.H., Badiwala M.V., Weisel R.D., Fedak P.W., Li R.K., et al. Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein. Circulation 2002, 105:1890-1896.
41. Prochazka V., Gumulec J., Jaluvka F., Salounova D., Jonszta T., Czerny D., et al. Cell therapy, a new standard in management of chronic critical limb ischemia and foot ulcer. Cell Transplant 2010, 19:1413-1424.
42. Fadini G.P., Sartore S., Albiero M., Baesso I., Murphy E., Menegolo M., et al. Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy. Arterioscler Thromb Vasc Biol 2006, 26:2140-2146.
43. DiPersio J.F. Diabetic stem-cell "mobilopathy". N Engl J Med 2011, 365:2536-2538.
44. Matoba S., Tatsumi T., Murohara T., Imaizumi T., Katsuda Y., Ito M., et al. Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia. Am Heart J 2008, 156:1010-1018.
45. Kinnaird T., Stabile E., Burnett M.S., Epstein S.E. Bone-marrow-derived cells for enhancing collateral development: mechanisms, animal data, and initial clinical experiences. Circ Res 2004, 95:354-363.